BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35201905)

  • 1. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides.
    Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
    Leuk Lymphoma; 2022 Jul; 63(7):1598-1606. PubMed ID: 35201905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperpigmented Mycosis Fungoides - A Rare Entity.
    Balić A; Jerković Gulin S; Čeović R; Ilić I; Radoš J
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):131-132. PubMed ID: 31351512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype.
    Pavlovsky L; Mimouni D; Amitay-Laish I; Feinmesser M; David M; Hodak E
    J Am Acad Dermatol; 2012 Jul; 67(1):69-75. PubMed ID: 21982059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
    Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
    Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
    Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
    J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides variants-clinicopathologic features, differential diagnosis, and treatment.
    Willemze R
    Semin Cutan Med Surg; 2018 Mar; 37(1):11-17. PubMed ID: 29719015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poiklodermatous variant of mycosis fungoides.
    Bukhari IA
    J Drugs Dermatol; 2006 Feb; 5(2):190-2. PubMed ID: 16485891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical heterogeneity of poikilodermatous mycosis fungoides: A retrospective study of 12 cases].
    Rohmer E; Mitcov M; Cribier B; Lipsker D; Lenormand C
    Ann Dermatol Venereol; 2020; 147(6-7):418-428. PubMed ID: 32229035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
    Titou H; Bouhamidi A
    Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical variants of mycosis fungoides in a cohort.
    Domínguez-Gómez MA; Reyes-Salcedo CA; Morales-Sánchez MA; Jurado-Santa CF
    Gac Med Mex; 2021; 157(1):41-46. PubMed ID: 34125823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
    El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
    Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poikilodermatous Mycosis Fungoides: Comparative Study of Clinical, Histopathological and Immunohistochemical Features.
    Vasconcelos Berg R; Valente NYS; Fanelli C; Wu I; Pereira J; Zatz R; Sanches JA
    Dermatology; 2020; 236(2):117-122. PubMed ID: 31550709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
    Wu JH; Cohen BA; Sweren RJ
    Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different faces of mycosis fungoides: results of a single-center study.
    Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
    Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
    Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
    J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides.
    Virmani P; Levin L; Myskowski PL; Flores E; Marchetti MA; Lucas AS; Pulitzer M; Horwitz S; Trippett T; Moskowitz A; Querfeld C
    Pediatr Dermatol; 2017 Sep; 34(5):547-553. PubMed ID: 28804919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.